AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates

BERWYN, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today unveiled its latest Specialty & Rare Pipeline Digest™, the industry’s most comprehensive digital resource for information on new, pending and upcoming specialty and rare disease drug launches and approvals, biosimilars and cell and gene therapies (CGTs). As the intricate specialty pharmaceutical landscape evolves with emerging therapies, this complimentary quarterly publication equips stakeholders with vital, timely updates into specialty product pipelines.

To read more, click here